Hepatogastroenterology Unit, 2nd Department of Internal Medicine and Research Institute, Attikon University General Hospital
Haidari, Attica, 12462, Greece
NCT Number: NCT02340065
The aim of this study is to evaluate Endocuff- assisted colonoscopy in terms of its possible additive contribution in the detection of important lesions, namely polyps and cancers, compared to standard colonoscopy, in a series of patients undergoing back-to-back screening or surveillance colonoscopies in a randomized fashion. Moreover, we aim to assess possible changes regarding post-polypectomy surveillance programs following Endocuff utilization.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Haidari, Attica, 12462, Greece
Tandem colonoscopies studies results, show that novel endoscopic technologies detect about 20% more adenomas than those conventional colonoscopy does (missed adenomas). Since Endocuff-assisted colonoscopy cannot be considered as a perfect examination, we hypothesize that conventional colonoscopy will detect one third of the missed adenomas that Endocuff-assisted colonoscopy detects in a similar setting. Therefore a sample size of 120 adenomas achieves 80% power to detect an odds ratio of 3.0 using a two-sided McNemar test with a significance level of 0.05. The odds ratio is equivalent to a difference between two paired proportions of 14% which occurs when the proportion of detected missed adenomas during Endocuff-assisted colonoscopy is 21% and the proportion of missed adenomas during conventional colonoscopy is 7%. During one year period before the study initiation, our colonoscopy performance quality data show that we detect a mean number of adenomas per patient equal of 0.7 in a population similar to the one recruited in our study. Therefore, 172 patients overall will be required to detect 120 adenomas. Given the uncertainty of our estimation and in order to cope with patients exclusions, withdrawals and unexpected incomplete colonoscopies, we decided to recruit 200 patients.
A more extensive description regarding the investigators study is provided in the following fields.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
examination of the colon with a conventional colonoscope
Other names: conventional colonoscopy
examination of the colon with Endocuff-assisted colonoscopy
Other names: Endocuff
Time frame: one week
in the entire colon
Time frame: one week
with both Endocuff-assisted and standard colonoscopy
Time frame: one week
with both Endocuff-assisted and standard colonoscopy
Time frame: one week
with both Endocuff-assisted and standard colonoscopy
Time frame: one week
with both Endocuff-assisted and standard colonoscopy
Time frame: one week
colonoscopy completion rate, reason for incomplete colonoscopy
Time frame: one week
for both Endocuff-assisted and standard colonoscopy (time spent for therapeutic procedures is excluded)
Time frame: one week
adverse event rate
Time frame: one week
endoscopist's satisfaction quantified using a scale from 0 (not satisfied) to 10 (completely satisfied) for Endocuff-assisted colonoscopy
Time frame: one week
with both Endocuff-assisted and standard colonoscopy
Attikon Hospital
Other
Endocuff-assisted vs. Standard Colonoscopy: a Randomized, Back-to-Back Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07508592
Body Weight, Colon Neoplasms
San Salvador, El Salvador
View Trial DetailsNCT00600496
Breast Cancer, Breast Diseases
Detroit, Michigan, United States
View Trial DetailsNCT03446157
Cancer of the Colon, Colon Cancer
Chapel Hill, North Carolina, United States
View Trial DetailsNCT04232176
Colon Cancer, Colon Neoplasms
Granada, Spain
View Trial Details